You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 158 No. 10, May 25, 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Observation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Psychiatry
 •Depression
 •Adverse Effects
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic

Elevated Serum Digoxin Level Associated With Coadministered Fluoxetine

Arthur Leibovitz, MD; Tamara Bilchinsky, MD; Israel Gil, MD; Beni Habot, MD

Arch Intern Med. 1998;158:1152-1153.

After her daughter died, depression developed in a 93-year-old woman with congestive heart failure receiving digoxin therapy. After treatment with fluoxetine hydrochloride she became anorexic and her serum digoxin level increased. A possible interaction, which has not been reported in the literature, may have occurred between fluoxetine and digoxin.


From the Shmuel Harofe Hospital, Geriatric Medical Center, Beer-Yacov, Israel (Dr Bilchinsky); and the Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel (Drs Leibovitz, Gil, and Habot).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Inhibition of P-Glycoprotein by Newer Antidepressants
Weiss et al.
J. Pharmacol. Exp. Ther. 2003;305:197-204.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.